KL and infection: By designing adenoviral vectors that mimic either the lactylated or delactylated forms of this site and employing adeno-associated viruses to specifically target osteoblasts, in vitro and in vivo studies suggest that modifying PGK1 at K361 through Kla may offer a promising strategy for treating infection-induced osteogenic dysfunction.